Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Talk with your doctor about potential risks associated with the procedure.
The primary risks of the renal denervation procedure are similar to the risks of all diagnostic procedures requiring catheterization of the arteries of the body. The following are potential risks of the catheterization procedure (including renal angiogram):
Uncommon < 10% (less than 1 in 10 chance), temporary and not severe unless otherwise indicated
Rare < 1% (less than 1 in 100 chance), temporary and not severe unless otherwise indicated
Very Rare < 0.1% (less than 1 in 1000 chance)
There are additional risks that could possibly be associated with the denervation procedure/response to treatment. These complications have not yet been quantified. These potential risks may include:
The device has not been evaluated in patients who are pregnant, nursing or plan to become pregnant.
© 2018 Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. All other brands are trademarks of a Medtronic company. ™* Third-party brands are trademarks of their respective owners. For distribution only in markets where the Symplicity Spyral™ multi-electrode renal denervation catheter and Symplicity G3™ renal denervation RF generator have been approved. Not for distribution in the USA, Japan, France, Denmark, Spain.